PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)
$23.2 -0.07 (-0.3008%)
Analysed PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) News Sources
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
09-04-2026
yahoo.com
Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?
08-04-2026
yahoo.com
EAU Upgrade Puts Aquablation And PROCEPT BioRobotics In Focus
27-03-2026
yahoo.com
PROCEPT BioRobotics (PRCT) Strengthens Its Case with Expanding System Base
26-03-2026
yahoo.com
Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
24-03-2026
yahoo.com
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
23-03-2026
yahoo.com
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
12-03-2026
yahoo.com
Procept BioRobotics price target lowered to $30 from $47 at Truist
03-03-2026
yahoo.com
PROCEPT BioRobotics Investor Day: 2026 growth targets, higher ASPs, and profitability roadmap
01-03-2026
marketbeat.com
A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 Outlook
28-02-2026
yahoo.com
What is the current price of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The current price of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is $23.2.
PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) since the previous trading day is $-0.07.
PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) since the previous trading day is -0.3008%.
What is the most recent average sentiment score for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The most recent average sentiment score for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The most recent sentiment for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is .
SEC-8K** Filing Available For PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.